Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 9Arthralgia 2Osteoporosis 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Hormone-receptor-positive Breast Cancer 1Hormone Receptor Positive Advanced Breast Cancer 1Fractures, Bone 1Fatigue 1Endometrial Neoplasms 1Advanced Breast Cancer 1

Interventions

Surveys and Questionnaires 16Blood Specimen Collection 7Observation 5Surgical Procedures, Operative 4Interviews as Topic 4Hysteroscopy 4Hysterectomy 4Ultrasonography 2Specimen Handling 2Sentinel Lymph Node Biopsy 2Reverse Transcriptase Polymerase Chain Reaction 2Psychiatric Rehabilitation 2Magnetic Resonance Spectroscopy 2Laparoscopy 2Immunohistochemistry 2High-Energy Shock Waves 2Drug Therapy 2Data Collection 2Biopsy 2Base Sequence 2trastuzumab deruxtecan 1sarcolipin 1rubitecan 1olaparib 1dostarlimab 1apixaban 1X-Rays 1Vaginal Smears 1Tissue Banks 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Endometrial Neoplasms × Aromatase Inhibitors × Clear all
NCT03621904 2023-01-18

PROMOTE

Radboud University Medical Center

Recruiting
150 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡